Evonik to retain specialty monomers division after methacrylates divestment

Katherine Sale

25-Sep-2018

LONDON (ICIS)–Evonik has decided to retain its specialty monomers division following the anticipated divestment of its methyl methacrylate (MMA) and polymethyl methacrylate (PMMA) business units, according to a letter to customers seen by ICIS on Tuesday.

Evonik MMA plant ShanghaiThe company announced in March this year that it is considering spinning off the divisions, with any potential sale potentially fetching a price tag of €1.8bn, according to market analysts.

The specialty monomers division had been expected to be part of the carve-out.

“Evonik’s experience has shown that its specialty methacrylates and its oil additives businesses complement each other,” said the producer.

“The group [with branded name] Visiomer specialty monomers from the Application Monomers product line will be integrated into the Evonik Resource Efficiency segment.”

Evonik’s delivery obligations remain in place, it told its customers.

Pictured: Evonik’s MMA plant in Shanghai
Source: Evonik

READ MORE

Global News + ICIS Chemical Business (ICB)

See the full picture, with unlimited access to ICIS chemicals news across all markets and regions, plus ICB, the industry-leading magazine for the chemicals industry.

Contact us

Partnering with ICIS unlocks a vision of a future you can trust and achieve. We leverage our unrivalled network of industry experts to deliver a comprehensive market view based on independent and reliable data, insight and analytics.

Contact us to learn how we can support you as you transact today and plan for tomorrow.

READ MORE